25.83
Overview
News
Price History
Option Chain
Financials
Why BAX Down?
Discussions
Forecast
Stock Split
Dividend History
Baxter International Inc stock is traded at $25.83, with a volume of 3.41M.
It is up +1.02% in the last 24 hours and down -8.89% over the past month.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.
See More
Previous Close:
$25.57
Open:
$25.33
24h Volume:
3.41M
Relative Volume:
0.53
Market Cap:
$13.35B
Revenue:
$11.32B
Net Income/Loss:
$-981.00M
P/E Ratio:
-13.22
EPS:
-1.9532
Net Cash Flow:
$714.00M
1W Performance:
-1.15%
1M Performance:
-8.89%
6M Performance:
+35.73%
1Y Performance:
+9.54%
Baxter International Inc Stock (BAX) Company Profile
Name
Baxter International Inc
Sector
Industry
Phone
(224) 948-2000
Address
ONE BAXTER PARKWAY, DEERFIELD, IL
Compare BAX vs ISRG, BDX, ALC, RMD, MDLN
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
BAX
Baxter International Inc
|
25.83 | 13.65B | 11.32B | -981.00M | 714.00M | -1.9532 |
|
ISRG
Intuitive Surgical Inc
|
366.70 | 132.30B | 11.03B | 3.16B | 3.22B | 8.7251 |
|
BDX
Becton Dickinson Co
|
184.74 | 51.11B | 21.37B | 1.41B | 3.07B | 3.9437 |
|
ALC
Alcon Inc
|
70.50 | 35.25B | 10.63B | 819.00M | 1.59B | 1.6577 |
|
RMD
Resmed Inc
|
228.35 | 32.95B | 5.54B | 1.52B | 1.74B | 10.37 |
|
MDLN
Medline Inc
|
36.59 | 28.58B | 29.14B | 1.07B | 1.05B | 1.1956 |
Baxter International Inc Stock (BAX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-31-25 | Downgrade | Argus | Buy → Hold |
| Aug-04-25 | Downgrade | Stifel | Buy → Hold |
| Aug-01-25 | Downgrade | Goldman | Buy → Neutral |
| Feb-26-25 | Resumed | Goldman | Buy |
| Feb-24-25 | Upgrade | Argus | Hold → Buy |
| Feb-20-25 | Resumed | Barclays | Overweight |
| Jul-15-24 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| May-30-24 | Initiated | Goldman | Neutral |
| May-10-24 | Downgrade | TD Cowen | Buy → Hold |
| May-30-23 | Resumed | Morgan Stanley | Equal-Weight |
| Mar-29-23 | Initiated | UBS | Neutral |
| Jan-06-23 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-05-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jan-03-23 | Downgrade | BofA Securities | Buy → Neutral |
| Dec-19-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Dec-15-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Dec-12-22 | Downgrade | Citigroup | Buy → Neutral |
| Oct-18-22 | Initiated | Barclays | Overweight |
| Oct-12-22 | Initiated | Jefferies | Hold |
| Jun-24-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Apr-04-22 | Downgrade | Goldman | Neutral → Sell |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Feb-18-22 | Reiterated | KeyBanc Capital Markets | Overweight |
| Feb-18-22 | Reiterated | Morgan Stanley | Overweight |
| Feb-18-22 | Reiterated | Raymond James | Outperform |
| Feb-18-22 | Reiterated | Stifel | Buy |
| Feb-18-22 | Reiterated | UBS | Neutral |
| Feb-18-22 | Reiterated | Wells Fargo | Overweight |
| Feb-11-22 | Initiated | Goldman | Neutral |
| Jan-07-22 | Resumed | Citigroup | Buy |
| Jan-07-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Sep-13-21 | Upgrade | Cowen | Market Perform → Outperform |
| Sep-03-21 | Upgrade | Barclays | Equal Weight → Overweight |
| May-25-21 | Initiated | Barclays | Equal Weight |
| Jan-29-21 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jan-06-21 | Downgrade | UBS | Buy → Neutral |
| Dec-15-20 | Downgrade | Goldman | Buy → Neutral |
| Oct-01-20 | Upgrade | Citigroup | Neutral → Buy |
| Sep-04-20 | Downgrade | Argus | Buy → Hold |
| Jun-24-20 | Initiated | Oppenheimer | Outperform |
| Mar-19-20 | Upgrade | Stifel | Hold → Buy |
| Mar-18-20 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Mar-05-20 | Initiated | Citigroup | Neutral |
| Feb-13-20 | Initiated | Goldman | Buy |
| Jan-02-20 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-17-19 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jun-26-19 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Apr-08-19 | Downgrade | Evercore ISI | Outperform → In-line |
| Jan-02-19 | Upgrade | Citigroup | Neutral → Buy |
| Jan-02-19 | Upgrade | Morgan Stanley | Underweight → Overweight |
| Nov-02-18 | Upgrade | Argus | Hold → Buy |
| Oct-16-18 | Initiated | Barclays | Underweight |
| May-17-18 | Resumed | Piper Jaffray | Overweight |
| Feb-06-18 | Reiterated | Citigroup | Neutral |
| Jan-03-18 | Initiated | Evercore ISI | Outperform |
| Jan-03-18 | Upgrade | Raymond James | Mkt Perform → Outperform |
View All
Baxter International Inc Stock (BAX) Latest News
Baxter International stock holds steady as investors await next earnings signal - AD HOC NEWS
BAX Raises 2026 Outlook as Strong Q2 Growth Offsets Margin Pressure - TradingView
Human Albumin Market Report Analyzes Growth Factors, Challenges, and Market Dynamics - openPR.com
Drug Reconstitution Systems Market Trends, Shares and Growth Opportunities Worldwide 2026-2035 Featuring Profiles of Baxter, ICU Medical, B. Braun, Vetter Pharma, Nipro, SCHOTT-KAISHA - GlobeNewswire Inc.
Don't Ignore The Insider Selling In Abeona Therapeutics - simplywall.st
Nagaraj Bhat Appointed Vice President/GM, Global Capability Center (GCC) Site Leader at DePuy Synthes - hrtoday.in
Baxter International stock holds steady as investors focus on recent restructuring and earnings prof - AD HOC NEWS
ETFs Investing in Baxter International Inc. Stocks - TradingView
Before Mark Walter’s companies faced inquiries, he kept a low profile and built loyalty - Los Angeles Times
Two IV Saline Recalls Within Days Cite Iron Oxide and Fiberglass Particles Found Inside Sealed Hospital Bags - Medical Daily
IV bags recalled in MD over potential fiberglass contamination - Maryland Daily Record
Baxter International Inc. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
Baxter International stock holds steady as investors digest latest quarterly figures - AD HOC NEWS
Jerry Flansburg Obituary (2026)International Falls, MNRainy Lake Gazette - Legacy obituary
Baxter International's Julie Foster Reports RSU-Related Share Forfeiture - Kalkine Media
Recalls issued for possible fiberglass particles in IV solutions made at WNC facility: FDA - WLOS
Baxter International stock gains after strong Q2 figures - AD HOC NEWS
Baxter International Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Taiwan's Best Companies to Work for in Asia Transformed a Talent Crisis into a Strategic Advantage - PR Newswire
Baxter International stock holds gains as recalls and earnings shape sentiment - AD HOC NEWS
Baxter International stock could double, Tom Hayes says - Yahoo Finance
FDA recalls saline bags in 14 states over possible fiberglass contamination - thecooldown.com
Baxter International stock steadies as recall news meets mixed analyst view - AD HOC NEWS
Baxter International Inc. (BAX) Stock Analysis: Exploring a 9.94% Potential Upside Amidst Healthcare Sector Dynamics - DirectorsTalk Interviews
2 drugs recalled over potential fiberglass, steel presence - WGN-TV
Saline bags recalled in 14 states due to potential fiberglass contamination - kare11.com
Fiberglass in IV saline? Texas among states included in recall - MySA
Baxter International Inc. (BAX) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Saline used in IV injections recalled nationwide due to fiberglass - FOX 8 News
Several Baxter vaccine, solution lots recalled due to potential ‘particulate matter’ - WFMJ
Baxter Recalls an IV Nutrition Solution After Stainless Steel Particles Turned Up Inside the Sterile Bag - Medical Daily
Baxter Issues Voluntary Nationwide Recall for One Lot of 70% Dextrose Injection Due to Potential Presence of Particulate Matter - EIN News
Baxter International Inc. (BAX) Stock Analysis: Navigating Challenges with Potential 9.06% Upside - DirectorsTalk Interviews
Baxter International stock holds steady as new CFO joins and analyst estimates shift - Ad-hoc-news.de
Zacks Research Issues Negative Estimate for BAX Earnings - MarketBeat
Mitsubishi UFJ Asset Management Co. Ltd. Takes Position in Baxter International Inc. $BAX - MarketBeat
Baxter International (BAX) Taps John Rogers As Chief Financial Officer - Sahm
Baxter hires new CFO with visa contingency - CFO Dive
Baxter hires CFO from Smith & Nephew - MedTech Dive
1,435,460 Shares in Baxter International Inc. $BAX Acquired by Tocqueville Asset Management L.P. - MarketBeat
Edmond DE Rothschild Holding S.A. Acquires New Shares in Baxter International Inc. $BAX - MarketBeat
Great Lakes Advisors LLC Purchases New Holdings in Baxter International Inc. $BAX - MarketBeat
BlackRock Inc. Makes New $1.74 Billion Investment in Baxter International Inc. $BAX - MarketBeat
Smith+Nephew CFO joins Baxter - MassDevice
Baxter International Inc. stock outperforms competitors on strong trading day - MarketWatch
Baxter finds its replacement finance chief, reaffirms outlook - Crain's Chicago Business
Form 8K BAXTER INTERNATIONAL INC For: 19 August By Investing.com - Investing.com South Africa
Baxter Appoints Smith+Nephew CFO John Rogers as Chief Financial Officer - citybiz
Baxter appoints John Rogers as CFO effective October 1 By Investing.com - Investing.com Nigeria
Baxter appoints John Rogers as CFO effective October 1 - Investing.com
Baxter International Names John Rogers Chief Financial Officer - marketscreener.com
Baxter International Inc Stock (BAX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):